News from the phase 2 clinical trial of with a chemical in green tea has been shown to improve cognitive ability in people with Down syndrome, according to researchers from the Centre for Genomic Regulation in Barcelona. The study will be published in The Lancet Neurology, but there are news reports outlining the preliminary results of this interesting study.
LuMind RDS funded researchers Dr. Jamie Edgin and Dr. Fabian Fernandez were asked to provide comments on the study. An excerpt from those remarks were included in an article in the Medicalxpress.com and other outlets. For a more detailed look at the study, please see the article posted on alphagalileo.org.